Clinical Research Forum named the BIOS CTCC study Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) one of the Top 10 2023 Clinical Research Achievement…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) has been named a finalist for the 2023 Clinical Research Achievement Awards. The Clinical Research Achievement…
Peripheral Modulation of Muscle Stiffness and Spasticity (also called Muscle Stiffness) is a cross-over trial of hyaluronidase to reverse upper limb muscle stiffness in patients…
Targeting Cognition in Early Alzheimer’s Disease by Improving Sleep with Trazodone (REST) is a phase 2 clinical trial examining trazodone’s effect on sleep in patients…
The Johns Hopkins University Division of Brain Injury Outcomes (BIOS) is pleased to announce the 2022 recipient of the Ann Dana Kusch Predoctoral Fellowship in…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) had its final results published in The New England Journal of Medicine on March 30th, 2022.…
Kids MoD PAH (Mono- vs. Duo Therapy for Pediatric Pulmonary Arterial Hypertension) will be the first investigator-initiated multicenter randomized clinical trial in North America to…
OPTIMISTmain (Optimal Post Tpa-Iv Monitoring in Ischemic Stroke) is an international trial comparing the impact of different intensities of nursing care monitoring for acute ischemic…
David Newman-Toker, MD, PhD, director of JHU’s Division of Neuro-Visual and Vestibular Disorders and a BIOS faculty member, was awarded the David Robinson Professorship in…
Renal Anhydramnios Fetal Therapy (RAFT) is a clinical trial focused on helping combat the effects of early pregnancy renal anhydramnios (EPRA). EPRA is a condition…